Media

ConvaTec Healthcare Announces 2011 Second Quarter Earnings Call

14 June 2011

Analyst and Investor Call To Be Held On August 23, 2011

SKILLMAN, NJ (August 18, 2011) - ConvaTec Healthcare today announced that it will report its 2011 second quarter earnings on Tuesday, August 23, 2011. David Johnson, CEO and George Kegler, CFO will host an analyst and investor call at 9:00 AM EDT live via telephone. Questions and answers will follow.

To participate in the conference call within the U.S. and Canada, dial (866) 701-0354.

To participate in the conference internationally, dial (708) 290-1340.

The conference ID is 91319635.

Participants should dial in 10 minutes prior to the start of the call. The Company's unaudited, 2011 Second Quarter Report will be filed on the Company's website prior to the call at www.convateccorporate.com under the Investor Community tab.

A replay of the conference call will be available two hours after the call. To access the conference call replay, please dial (855) 859-2056 or (404) 537-3406 and reference conference ID 91319635. The replay will be available until October 7, 2011.

For more information, please contact investorrelations@convatec.com

About ConvaTec

ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas - Ostomy Care, Wound Therapeutics, Continence and Critical Care, and Infusion Devices - ConvaTec products support healthcare professionals from the hospital to the community health setting.

###

 

 

Cookies are needed for this website to work optimally. They also help us to know a little bit about how you use our website, which improves the browsing experience.  Cookies on this site are used for traffic measurement and optimisation of page content only. By continuing to browse on this website, you indicate your consent to the use of cookies.  You may block the use of cookies by following the "How to block and avoid cookies" instructions

Learn more about our Cookie policy